323 related articles for article (PubMed ID: 28159573)
1. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN
EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573
[TBL] [Abstract][Full Text] [Related]
2. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
3. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
4. CD8
Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
[TBL] [Abstract][Full Text] [Related]
5. Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
Tomescu C; Duh FM; Hoh R; Viviani A; Harvill K; Martin MP; Carrington M; Deeks SG; Montaner LJ
AIDS; 2012 Sep; 26(15):1869-78. PubMed ID: 22874514
[TBL] [Abstract][Full Text] [Related]
6. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD
AIDS; 2013 Feb; 27(4):519-28. PubMed ID: 23364441
[TBL] [Abstract][Full Text] [Related]
7. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
[TBL] [Abstract][Full Text] [Related]
8. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
[TBL] [Abstract][Full Text] [Related]
9. Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.
O'Connell KA; Han Y; Williams TM; Siliciano RF; Blankson JN
J Virol; 2009 May; 83(10):5028-34. PubMed ID: 19211742
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
[TBL] [Abstract][Full Text] [Related]
11. Case report: mechanisms of HIV elite control in two African women.
Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.
He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C
J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484
[TBL] [Abstract][Full Text] [Related]
13. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in
Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B
Front Immunol; 2018; 9():1855. PubMed ID: 30147699
[No Abstract] [Full Text] [Related]
14. Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.
Veenhuis RT; Kwaa AK; Garliss CC; Latanich R; Salgado M; Pohlmeyer CW; Nobles CL; Gregg J; Scully EP; Bailey JR; Bushman FD; Blankson JN
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232278
[TBL] [Abstract][Full Text] [Related]
15. Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.
Buckheit RW; Allen TG; Alme A; Salgado M; O'Connell KA; Huculak S; Falade-Nwulia O; Williams TM; Gallant JE; Siliciano RF; Blankson JN
Nat Commun; 2012 Mar; 3():716. PubMed ID: 22395607
[TBL] [Abstract][Full Text] [Related]
16. Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.
Yue L; Pfafferott KJ; Baalwa J; Conrod K; Dong CC; Chui C; Rong R; Claiborne DT; Prince JL; Tang J; Ribeiro RM; Cormier E; Hahn BH; Perelson AS; Shaw GM; Karita E; Gilmour J; Goepfert P; Derdeyn CA; Allen SA; Borrow P; Hunter E
PLoS Pathog; 2015 Jan; 11(1):e1004565. PubMed ID: 25569444
[TBL] [Abstract][Full Text] [Related]
17. Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption.
Schweighardt B; Wrin T; Meiklejohn DA; Spotts G; Petropoulos CJ; Nixon DF; Hecht FM
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):36-46. PubMed ID: 19910798
[TBL] [Abstract][Full Text] [Related]
18. HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells.
Martini F; Agrati C; D'Offizi G; Poccia F
Int J Immunopathol Pharmacol; 2005; 18(2):269-76. PubMed ID: 15888249
[TBL] [Abstract][Full Text] [Related]
19. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.
Walker-Sperling VE; Buckheit RW; Blankson JN
J Virol; 2014 Sep; 88(17):9789-98. PubMed ID: 24942573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
